For more than 25 years, Biomedical Development Corporation has been bringing commercially-viable products to market by linking promising technologies with vital sources of research funding.
Dr. Charles L. Bowden, M.D.
Susan L. McElroy, M.D.
Rif S. El-Mallakh, M.D.
National Institute of Mental Health (NIMH)
The goal of this project is to complete the development of a patient-centered software system and mobile app to assist in managing bipolar disorder. The clinical trial (n=120) is a randomized 52 week, blinded rater comparison of KIOS Bipolar to a popular mood charting program.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Lutz, Corrine K.
President and Fellows of Harvard Medical School
This research is designed to improve the quality of the research resource. Rhesus monkeys are crucial in the development of models for many human diseases. The goal of this project is to determine the factors that contribute to the development of severely abnormal Behavior in rhesus monkeys and to identify strategies for prevention and treatment.